| Application no. and date | 12753867.6 (espacenet) (Federated) (European Patent Register), 20120815 | | Patent/reg. no. and date | DK/EP 2744810, 20161005 | | Publication date | 20140625 | | Priority no. and date | US 201161524224 P, 20110816 | | EP pub. no. and date |
EP 2744810 20140625 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | P59867DK01 | | Inventor | LIU, Dazhan, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
SHI, Bing, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
WANG, Fang, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
YU, Richard, Hung Chiu, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/52 (2006.01) , A61P 31/18 (2006.01) , A61P 31/20 (2006.01) , C07D 473/34 (2006.01) | | Title | TENOFOVIR-ALAFENAMID-HEMIFUMARAT | | Int. application no. | US2012050920 | | Int. publication no. | WO2013025788 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
